These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 25961935)

  • 21. Nuclear Expression of CAMTA1 Distinguishes Epithelioid Hemangioendothelioma From Histologic Mimics.
    Doyle LA; Fletcher CD; Hornick JL
    Am J Surg Pathol; 2016 Jan; 40(1):94-102. PubMed ID: 26414223
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Novel detection of the CAMTA1-WWTR1 fusion gene in extra-adrenal myelolipoma-like lesion: a case report.
    Watanabe H; Murakami K; Motoi T; Murakami K; Aoyama Y; Mitomo H; Ishibashi N; Sugawara T; Tabata T; Matsuura T; Sasano H; Nakamura Y
    Virchows Arch; 2022 Mar; 480(3):707-712. PubMed ID: 34231054
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic stratification of clinical and molecular epithelioid hemangioendothelioma subsets.
    Rosenbaum E; Jadeja B; Xu B; Zhang L; Agaram NP; Travis W; Singer S; Tap WD; Antonescu CR
    Mod Pathol; 2020 Apr; 33(4):591-602. PubMed ID: 31537895
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Case of epithelioid hemangioendothelioma occurring in the postradiation setting for breast cancer.
    Hahn E; Dickson BC; Gupta AA; Nofech-Mozes S
    Genes Chromosomes Cancer; 2021 Feb; 60(2):112-115. PubMed ID: 33125182
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CAMTA-1 Expression in 24 Cases of Hepatic Epithelioid Hemangioendothelioma in a Single Institute: Diagnostic Utility for Differential Diagnosis from Hepatic Angiosarcoma.
    Jung H; Kim HN; Jang Y; Park CK; Ha SY
    In Vivo; 2019; 33(6):2293-2297. PubMed ID: 31662570
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Hippo effector TAZ (WWTR1) transforms myoblasts and TAZ abundance is associated with reduced survival in embryonal rhabdomyosarcoma.
    Mohamed A; Sun C; De Mello V; Selfe J; Missiaglia E; Shipley J; Murray GI; Zammit PS; Wackerhage H
    J Pathol; 2016 Sep; 240(1):3-14. PubMed ID: 27184927
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Poor response to sintilimab plus chemotherapy in a pulmonary epithelioid hemangioendothelioma patient: a case report.
    Zeng H; Tang X; Tian X; Liu Y; Tian P
    Immunotherapy; 2023 Feb; 15(2):77-83. PubMed ID: 36695105
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pleural epithelioid hemangioendothelioma harboring CAMTA1 rearrangement.
    Ha SY; Choi IH; Han J; Choi YL; Cho JH; Lee KJ; Sun JM
    Lung Cancer; 2014 Mar; 83(3):411-5. PubMed ID: 24461304
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The hippo tumor pathway promotes TAZ degradation by phosphorylating a phosphodegron and recruiting the SCF{beta}-TrCP E3 ligase.
    Liu CY; Zha ZY; Zhou X; Zhang H; Huang W; Zhao D; Li T; Chan SW; Lim CJ; Hong W; Zhao S; Xiong Y; Lei QY; Guan KL
    J Biol Chem; 2010 Nov; 285(48):37159-69. PubMed ID: 20858893
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Epithelioid hemangioendothelioma-its history, clinical features, molecular biology and current therapy.
    Tsuchihashi K; Baba E
    Jpn J Clin Oncol; 2024 Jul; 54(7):739-747. PubMed ID: 38555494
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Epithelioid hemangioendothelioma with extensive cystic change and CAMTA1 rearrangement.
    Lee SE; Park HY; Kim S; Bang H; Min JH; Choi YL
    Pathol Int; 2013 Oct; 63(10):502-5. PubMed ID: 24134632
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Diagnostic challenges on breast needle core biopsies. Case 6: Epithelioid hemangioendothelioma].
    Weingertner N
    Ann Pathol; 2017 Oct; 37(5):396-401. PubMed ID: 28943201
    [No Abstract]   [Full Text] [Related]  

  • 33. Epithelioid Hemangioendothelioma Arising Within Mediastinal Myelolipoma: A WWTR1-Driven Composite Neoplasm.
    Diaz-Perez JA; Velez-Torres J; Iakymenko O; Villamizar N; Rosenberg AE
    Int J Surg Pathol; 2019 Sep; 27(6):664-668. PubMed ID: 30942102
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Primary Intranodal Epithelioid Hemangioendothelioma with Molecular Confirmation.
    Vazzano JL; Patton A; Tinoco G; Iwenofu OH
    Int J Surg Pathol; 2022 Aug; 30(5):557-563. PubMed ID: 35098778
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CAMTA1 immunostaining is not useful in differentiating epithelioid hemangioendothelioma from its potential mimickers.
    Yusıflı Z; Kösemehmetoğlu K
    Turk Patoloji Derg; 2014; 30(3):159-65. PubMed ID: 25110239
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Common Secondary Genomic Variants Associated With Advanced Epithelioid Hemangioendothelioma.
    Seligson ND; Awasthi A; Millis SZ; Turpin BK; Meyer CF; Grand'Maison A; Liebner DA; Hays JL; Chen JL
    JAMA Netw Open; 2019 Oct; 2(10):e1912416. PubMed ID: 31577358
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CSE1L promotes nuclear accumulation of transcriptional coactivator TAZ and enhances invasiveness of human cancer cells.
    Nagashima S; Maruyama J; Honda K; Kondoh Y; Osada H; Nawa M; Nakahama KI; Ishigami-Yuasa M; Kagechika H; Sugimura H; Iwasa H; Arimoto-Matsuzaki K; Nishina H; Hata Y
    J Biol Chem; 2021 Jul; 297(1):100803. PubMed ID: 34022224
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cytologic features and immunohistochemical findings of epithelioid hemangioendothelioma (EHE) in effusion: A case series.
    Jebastin Thangaiah J; Hanley K; Nomani L; Policarpio-Nicolas ML
    Diagn Cytopathol; 2021 Jan; 49(1):E24-E30. PubMed ID: 32797671
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Recurrent WWTR1 S89W mutations and Hippo pathway deregulation in clear cell carcinomas of the cervix.
    Kim SH; Basili T; Dopeso H; Da Cruz Paula A; Bi R; Issa Bhaloo S; Pareja F; Li Q; da Silva EM; Zhu Y; Hoang T; Selenica P; Murali R; Chan E; Wu M; Derakhshan F; Maroldi A; Hanlon E; Ferreira CG; Lapa E Silva JR; Abu-Rustum NR; Zamarin D; Chandarlapaty S; Matrai C; Yoon JY; Reis-Filho JS; Park KJ; Weigelt B
    J Pathol; 2022 Aug; 257(5):635-649. PubMed ID: 35411948
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The ciliopathy disease protein NPHP9 promotes nuclear delivery and activation of the oncogenic transcriptional regulator TAZ.
    Habbig S; Bartram MP; Sägmüller JG; Griessmann A; Franke M; Müller RU; Schwarz R; Hoehne M; Bergmann C; Tessmer C; Reinhardt HC; Burst V; Benzing T; Schermer B
    Hum Mol Genet; 2012 Dec; 21(26):5528-38. PubMed ID: 23026745
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.